These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8359354)

  • 1. Urinary and plasma glycosaminoglycans in endocrine ophthalmopathy.
    Schuler M; Hansen C; Winand R; Stover C; Otto E; Beyer J; Kahaly G
    Dev Ophthalmol; 1993; 25():58-67. PubMed ID: 8359354
    [No Abstract]   [Full Text] [Related]  

  • 2. Orbital connective tissue in endocrine ophthalmopathy.
    Bahn RS; Heufelder AE
    Dev Ophthalmol; 1993; 25():46-57. PubMed ID: 8359353
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary glycosaminoglycans in Graves' ophthalmopathy.
    Kahaly G; Schuler M; Sewell AC; Bernhard G; Beyer J; Krause U
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):35-44. PubMed ID: 2401097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary glycosaminoglycans in active Graves ophthalmopathy.
    Martínez-Brú C; Ampudia X; Castrillo P; González-Sastre F
    Clin Chem; 1992 Nov; 38(11):2341. PubMed ID: 1424139
    [No Abstract]   [Full Text] [Related]  

  • 5. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy.
    Glinoer D; Etienne-Decerf J; Schrooyen M; Sand G; Hoyoux P; Mahieu P; Winand R
    Acta Endocrinol (Copenh); 1986 Jan; 111(1):30-8. PubMed ID: 2868602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of urinary mucopolysaccharides in Graves' disease.
    Ursu H; Dumitrescu C; Bartoc R; Dumitriu L
    Endocrinologie; 1984; 22(4):277-82. PubMed ID: 6240765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The assessment of urinary glycosaminoglycans (GAG) excretion during therapy of patients with progressive Graves' ophthalmopathy].
    Pilarska K; Kulig G; Krzystolik Z
    Pol Arch Med Wewn; 2001 Feb; 105(2):139-44. PubMed ID: 11505748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary glycosaminoglycans excretion in Graves' disease.
    Priestley GC; Aldridge RD; Hurel S
    Acta Derm Venereol; 1996 Sep; 76(5):368-70. PubMed ID: 8891010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycans in thyroid eye disease.
    Kahaly G; Förster G; Hansen C
    Thyroid; 1998 May; 8(5):429-32. PubMed ID: 9623737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sulfatation of orbital glycosaminoglycans in Graves' ophthalmopathy.
    Hansen C; Rouhi R; Förster G; Kahaly GJ
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1409-13. PubMed ID: 10199787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ultrastructural and systemic analysis of glycosaminoglycans in thyroid-associated ophthalmopathy.
    Pappa A; Jackson P; Stone J; Munro P; Fells P; Pennock C; Lightman S
    Eye (Lond); 1998; 12 ( Pt 2)():237-44. PubMed ID: 9683947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-magnetic resonance spectroscopy of retrobulbar tissue in Graves ophthalmopathy.
    Ohtsuka K; Hashimoto M
    Am J Ophthalmol; 1999 Dec; 128(6):715-9. PubMed ID: 10612507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy.
    Glinoer D; Etienne-Decerf J; Schrooyen M; Sand G; Hoyoux P; Mahieu P; Winand R
    Metab Pediatr Syst Ophthalmol (1985); 1988; 11(3):133-40. PubMed ID: 3205168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of endocrine exophthalmia].
    Winand R
    Bull Acad R Med Belg; 1974 Oct; 13(9):717-30. PubMed ID: 4278711
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acid mucopolysaccharide content of the blood in patients with diffuse toxic goiter and ophthalmopathy].
    Oleĭnik VA; Kamenetskaia MS
    Vrach Delo; 1988 Jul; (7):70-2. PubMed ID: 2973180
    [No Abstract]   [Full Text] [Related]  

  • 16. [The metabolism of glycosaminoglycans in the course of Graves' disease].
    Winsz-Szczotka K; Komosińska-Vassev K; Olczyk K
    Postepy Hig Med Dosw (Online); 2006; 60():184-91. PubMed ID: 16618989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy.
    Marinò M; Lisi S; Pinchera A; Marcocci C; Menconi F; Morabito E; Macchia M; Sellari-Franceschini S; McCluskey RT; Chiovato L
    Thyroid; 2003 Sep; 13(9):851-9. PubMed ID: 14588099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of practical methods for urinary glycosaminoglycans and serum hyaluronan with clinical activity scores in patients with Graves' ophthalmopathy.
    Martins JR; Furlanetto RP; Oliveira LM; Mendes A; Passerotti CC; Chiamolera MI; Rocha AJ; Manso PG; Nader HB; Dietrich CP; Maciel RM
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):726-33. PubMed ID: 15163337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum glycosaminoglycans in Graves' disease patients].
    Winsz-Szczotka KB; Olczyk KZ; Koźma EM; Komosińska-Vassev KB; Wisowski GR; Marcisz C
    Wiad Lek; 2006; 59(1-2):66-71. PubMed ID: 16646296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxoedema.
    Chang CC; Chang TC; Kao SC; Kuo YF; Chien LF
    Acta Endocrinol (Copenh); 1993 Oct; 129(4):322-7. PubMed ID: 8237250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.